Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How often can cosentyx dosage be adjusted for better results?How does albumin binding affect paclitaxel's tissue distribution?Skyrizi loss of exclusivity?What's the cost of fintepla for pharmacies?Lipitor's digestive issues how do they change drug's potency?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) received its initial FDA approval on September 4, 2014. [1]
That first FDA approval (September 4, 2014) was for unresectable or metastatic melanoma. [1]
Other Questions About Keytruda :